Delivery Order SPE2DR25D9114-SPE2DR26FMEL5
Award Date 2/23/26
Potential Completion Date 3/16/26
Potential Value $22K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for Vabysmo 6 mg/0.05 mL syringes, with a ceiling value of $14,702.80, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to...
- The Defense Logistics Agency issued a $5,881.12 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 11, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for VABYSMO 6 MG/0.05 ML syringes. PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract authorizing firm fixed-price orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 20, 2026, with a ceiling value of $8,749.60 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 12, 2026, with a ceiling value of $3,986.30, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical supply. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting recurring pharmaceutical and medical consumable supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small...
- The Defense Logistics Agency issued a $26,532.96 delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products supporting Department of Defense medical supply needs. PPV-G GEN V is a $30.3 billion acquisition strategy establishing multiple regional prime vendor contractors to supply branded and generic prescription drugs, over-the-counter medications,...
- The Defense Logistics Agency issued a $1,617.78 delivery order to DMS Pharmaceutical Group Inc. on February 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract supporting recurring pharmaceutical supply needs for Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned...
- The Defense Logistics Agency issued a $151,959.24 delivery order to DMS Pharmaceutical Group Inc. on February 13, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, with a ceiling value of $8,431.61 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, with a ceiling value of $8,844.32 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 12, 2026, with a ceiling value of $163,578.35, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription...